Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Revumenib (trade name: Revuforj) is an oral, first-in-class targeted Menin inhib···【more】
Release date：2026-01-29Recommended：116
Revumenib (trade name: Revuforj) is an oral targeted drug of the Menin inhibitor···【more】
Release date：2026-01-29Recommended：112
Revuforj carries a risk of differentiation syndrome, and patients and their fami···【more】
Release date：2026-01-29Recommended：122
Rivimeinib is available in three tablet strengths: 25 mg, 110 mg, and 160 mg.Wha···【more】
Release date：2026-01-28Recommended：110
Combination of this class of drugs with Revuforj is not recommended; if co-admin···【more】
Release date：2026-01-28Recommended：107
Remission is the primary treatment goal for acute myeloid leukemia (AML) and acu···【more】
Release date：2026-01-28Recommended：120
Administration of rivoceranib is continued until disease progression, occurrence···【more】
Release date：2026-01-28Recommended：112
The recommended dosage of Revuforj varies according to the patient's body we···【more】
Release date：2026-01-28Recommended：95
Take Revuforj exactly as directed by your healthcare provider. Do not change you···【more】
Release date：2026-01-28Recommended：113
Your doctor may prescribe Revuforj tablets in multiple dosage strengths, and it ···【more】
Release date：2026-01-28Recommended：84
Revumenib is a menin inhibitor that blocks the interaction between wild-type lys···【more】
Release date：2026-01-28Recommended：83
Revuforj tablets are available in different dosage strengths, each corresponding···【more】
Release date：2026-01-28Recommended：106
